RBBAX | SCUPX | RBBAX / SCUPX | |
Total Expense Ratio | 0.97 | 1.80 | 54% |
Annual Report Gross Expense Ratio | 0.97 | 1.80 | 54% |
Fund Existence | 20 years | 24 years | - |
Gain YTD | 8.481 | 6.777 | 125% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 2000 | 1000 | 200% |
Min. Initial Investment IRA | 1000 | N/A | - |
Net Assets | 853M | 2.25B | 38% |
Annual Yield % from dividends | 3.74 | 1.98 | 189% |
Returns for 1 year | 7.08 | 5.94 | 119% |
Returns for 3 years | 23.09 | 19.89 | 116% |
Returns for 5 years | 17.00 | 9.52 | 179% |
Returns for 10 years | 51.11 | 24.63 | 208% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BSR | 29.42 | 0.23 | +0.80% |
Beacon Selective Risk ETF | |||
PFD | 11.64 | 0.06 | +0.52% |
Flaherty & Crumrine Preferred and Income Fund | |||
FNDA | 31.53 | 0.15 | +0.48% |
Schwab Fundamental U.S. Small CompanyETF | |||
PPH | 89.03 | N/A | N/A |
VanEck Pharmaceutical ETF | |||
MRAL | 16.77 | -0.01 | -0.03% |
GraniteShares 2x Long MARA Daily ETF |